Fezolinetant impact on health-related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials

  1. Cano, A.
  2. Nappi, R.E.
  3. Santoro, N.
  4. Stute, P.
  5. Blogg, M.
  6. English, M.L.
  7. Morga, A.
  8. Scrine, L.
  9. Siddiqui, E.
  10. Ottery, F.D.
Revue:
BJOG: An International Journal of Obstetrics and Gynaecology

ISSN: 1471-0528,  1470-0328

Année de publication: 2024

Type: Article

DOI: 10.1111/1471-0528.17773 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus